AGIO compared with CRNX: revenue, margins and what each company keeps, and the suppliers and customers both name

AGIOAgios Pharmaceuticals, Inc.

Mkt capRevenueRevenue

CRNXCrinetics Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

AGIOAgios Pharmaceuticals, Inc.

CRNXCrinetics Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AGIO 4

ALNYAlnylamsupplier

—Avanzanite Bioscienceunlistedcustomer

—NewBridge Pharmaceuticals FZ-unlistedcustomer

—Royalty Pharma Investments 2019 ICAVunlistedcustomer

Shared 0

No shared counterparties.

Only CRNX 3

—SKKunlistedcustomer

—Loyalunlistedcustomer

—Sanwa Kagaku Kenkyushounlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

AGIOAgios Pharmaceuticals, Inc.

30.54· pre 30.93

Mkt cap$1.8BRevenue$45MQ2 FY26Revenue$54MFY25

CRNXCrinetics Pharmaceuticals, Inc.

84.97· pre 84.97· delayed

Pre-marketSep 2 '83

Mkt cap$509.7MRevenue$25MQ2 FY26Revenue$8MFY25

Compare

Pre-marketSep 2 '83

AGIOAgios Pharmaceuticals, Inc.

CRNXCrinetics Pharmaceuticals, Inc.

30.54pre 30.93

Price

84.97pre 84.97delayed

$1.8B

Mkt cap

$509.7M

Q2 FY26$45M

Revenue

$25MQ2 FY26

FY25$54M

Revenue

$8MFY25

AGIO30.54vsCRNX84.97Pre-marketSep 2 '83